[ Price : $8.95]
Bayer submits a supplemental NDA for oral androgen receptor inhibitor Nubeqa (darolutamide), seeking approval for its use in combi...[ Price : $8.95]
The FDA Oncology Drugs Advisory Committee votes not to recommend using immune checkpoint inhibitors in first-line advanced gastric...[ Price : $8.95]
AbbVie says a pivotal Phase 3 (TEMPO-1) trial for tavapadon in early Parkinsons disease met its primary and secondary endpoints.[ Price : $8.95]
Federal Register notice: FDA proposes to reclassify qualitative hepatitis B virus (HBV) antigen assays, qualitative and quantitati...[ Price : $8.95]
Federal Register notice: FDA, CDC, and NIH announce an 11/25 public workshop entitled Live Biotherapeutic Products to Prevent Necr...[ Price : $8.95]
Two drug trade associations support an FDA approach to postapproval manufacturing changes in biosimilar and interchangeable biosim...[ Price : $8.95]
FDA approves AstraZenecas Tagrisso for some non-small cell lung cancers.[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Medical Device Recall Authority.